Welcome to our dedicated page for DOCGO news (Ticker: DCGO), a resource for investors and traders seeking the latest updates and insights on DOCGO stock.
DocGo Inc. reports developments in technology-enabled mobile health, medical transportation, remote patient monitoring and virtual care. The company’s care delivery platform combines in-home or workplace treatment with remote physicians, a 50-state virtual care network and integrated Ambulnz medical transport services.
Recurring news themes include quarterly and annual results, revenue guidance, customer expansions, EMS hiring and efficiency initiatives, investor conference presentations, governance and compliance recognition, and activity at SteadyMD, DocGo’s virtual care division. Company updates also describe demand for clinician-led telehealth programs, including branded GLP-1 weight loss care support.
DocGo (Nasdaq: DCGO) reported second quarter 2026 revenue of $73.4 million, down from $80.4 million a year earlier, with the decline attributed entirely to the wind-down of migrant-related programs. Excluding these programs, revenue grew 19% year over year. GAAP gross margin was 26.9%, and net loss was approximately $18.0 million, while adjusted EBITDA was a loss of $6.3 million.
The company signed a definitive agreement to acquire virtual care provider Hicuity Health, which generated about $65 million in trailing 12‑month revenue and $4.5 million of adjusted EBITDA. DocGo will assume approximately $52 million of Hicuity debt held by Perceptive Advisors, and Hicuity’s preferred shareholder will receive equity equal to about 2% of DocGo’s current shares plus up to an additional 3.5% contingent on future market capitalization. Perceptive Advisors also committed to provide up to $50 million in additional debt financing. DocGo narrowed 2026 revenue guidance to $305–$310 million and reduced adjusted EBITDA guidance to a loss of $17–$22 million, while reiterating expectations to exit 2026 at a profitable adjusted EBITDA run rate.
DocGo (Nasdaq: DCGO) will release its financial results for the second quarter ended June 30, 2026, after U.S. markets close on Monday, August 17, 2026. Management will host a conference call and webcast at 5:00 p.m. ET the same day to discuss the results.
Investors can join via phone at 1-800-717-1738 (U.S.) or 1-646-307-1865 (international) using Conference ID 78516, or access a live webcast under the Events section of DocGo’s investor relations website.
DocGo (Nasdaq: DCGO) announced that subsidiary PTI Health by DocGo has launched mobile phlebotomy services in Southern Florida and expanded its relationship with a major national clinical laboratory across the Southeast.
The business uses a low capital investment model and targets Florida’s large older adult population with at-home blood collection and testing, leveraging existing partner ordering platform integrations as part of DocGo’s broader “healthcare at any address” strategy.
DocGo (Nasdaq: DCGO) announced that CEO Lee Bienstock will join a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, from 3:20–3:55 PM Eastern Time.
A live webcast will be accessible via DocGo’s investor relations website.
DocGo (Nasdaq: DCGO) reported Q1 2026 revenue of $75.6 million, down from $96.0 million due to the wind-down of migrant-related programs. Excluding those programs, revenue rose 19.3% year-over-year.
Net loss was $16.7 million and adjusted EBITDA was ($10.2) million. 2026 revenue guidance increased to $300–$315 million, with adjusted EBITDA expected at ($5)–($10) million. Mobile Health revenue excluding migrant programs grew 131%, healthcare-at-any-address revenue rose 36% sequentially, and DocGo highlighted strong volume growth across major service lines.
DocGo (Nasdaq: DCGO) announced that CEO Lee Bienstock will present at the 21st Annual Needham Technology, Media, & Consumer Conference on Thursday, May 14, 2026, from 11:45–12:25 PM ET. The presentation will include 1x1 meetings and a live webcast.
A webcast will be available on DocGo's investor relations website.
DocGo (Nasdaq: DCGO) will release first-quarter 2026 financial results after market close on Monday, May 11, 2026. Management will host a conference call and webcast the same day at 5:00 p.m. ET to discuss results and take questions.
Dial-in and webcast access are provided for U.S. and international participants, plus a Call me™ feature and an archived webcast on the company investor website.
DocGo (Nasdaq: DCGO) was named one of Ethisphere’s 2026 World’s Most Ethical Companies®, its first time receiving the honor. DocGo is one of four honorees in the healthcare providers and services category; 138 organizations across 17 countries and 40 industries were recognized in 2026.
The recognition cites DocGo’s governance, compliance, training, confidential reporting channels, and its use of Ethisphere’s Ethics Quotient®, which evaluates 240+ documented proof points.
DocGo (Nasdaq: DCGO) reported Q4 and full-year 2025 results and raised 2026 guidance after customer expansions and efficiency gains. Q4 revenue was $74.9M (Q4 2024: $120.8M) and full-year revenue was $322.2M (2024: $616.6M), driven by wind-down of migrant-related programs. GAAP gross margin was 27.2% in Q4; adjusted EBITDA loss improved to a projected $5–$10M for 2026. The company recorded significant non-cash impairments in 2025 and acquired SteadyMD on October 20, 2025.
DocGo (Nasdaq: DCGO) will release its fourth quarter and full year 2025 financial results after market close on Monday, March 16, 2026. Management will host a conference call and webcast at 5:00 p.m. ET to discuss results and the company outlook for 2026.
Investors can join by phone (U.S. 1-800-717-1738; international 1-646-307-1865) using Conference ID 74028, or listen via the webcast under Events on the company investor website.